Tag: #Global Trends

Swedish Orphan Biovitrum (SOBI) has reached an agreement to acquire Arthrosi Therapeutics Inc., a late-stage biotechnology company developing a highly... Read more

The U.S. Food and Drug Administration (FDA) has granted an expanded approval for a targeted combination therapy for patients with... Read more

The U.S. Food and Drug Administration (FDA) has "proactively" awarded Johnson & Johnson (J&J) a Commissioner’s National Priority Voucher (CNPV)... Read more

The U.S. Food and Drug Administration (FDA) recently granted approval for a new combination regimen for patients with unresectable or... Read more

Occupational health specialist Concentra (NYSE:CON), a publicly traded company, has expanded its national footprint by establishing a new medical center... Read more

Zealand Pharma A/S and OTR Therapeutics have announced a strategic collaboration and license agreement focused on the discovery and development... Read more

China’s National Medical Products Administration (NMPA) has granted approvals for two of Sanofi's rare hematologic disease treatments: Qfitlia (fitusiran) and... Read more

Negotiators from the European Parliament (EP) and the EU Council have reached a provisional agreement on a new regulatory framework... Read more